Skip to content
DataLookout
Menu

CROWDNCT06908070

Chemoradiotherapy With Surgery Followed by Consolidation Durvalumab

StatusRecruiting
PhasePhase 4
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 1 with changes below, 1 re-verified with no change.

  1. Study First Submitted

Endpoints

Primary

The rates of severe surgical morbidity and mortality
Timeframe: Within 90-days of surgery
Percentage of patients with high-grade treatment-related adverse events
Timeframe: Within 90-days of surgery
Proportion of patients proceeding to durvalumab consolidation after surgery
Timeframe: Within 2 months

Secondary (2)

R0 rate
DFS at 2 years

Arms and interventions

Chemoradiotherapy plus surgery and immunotherapyExperimental

Chemoradiotherapy followed by surgery and consolidation durvalumab

Drugs: Consolidation durvalumab

Sites

1 site in 1 country

  • Amsterdam UMC, location VU Medical centerAmsterdam, Netherlands